Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schramm

Showing results (111-120 of 228) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compoundsKatleen De Preter, Sara De Brouwer, Tom Van Maerken, et al.
Frontiers in Genetics|June 17, 2022
Detection and Validation of Circular DNA Fragments Using Nanopore SequencingAlicia Isabell Tüns, Till Hartmann, Simon Magin, et al.
Cancer Immunology, Immunotherapy : CII|June 17, 2015
Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in miceAlexander Stermann, Nicole Huebener, Diana Seidel, et al.
Biomaterials|June 14, 2006
Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of miceMartin Rücker, Matthias W Laschke, Dominik Junker, et al.
DNA Repair|August 6, 2008
Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cellsJohannes H Schulte, Steffi Kuhfittig-Kulle, Ludger Klein-Hitpass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Translating expression profiling into a clinically feasible test to predict neuroblastoma outcomeAlexander Schramm, Jo Vandesompele, Johannes H Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Polo-like kinase 1 is a therapeutic target in high-risk neuroblastomaSandra Ackermann, Felix Goeser, Johannes H Schulte, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 6, 2025
Risk profile for recurrence after interdisciplinary treatment of odontogenic maxillary sinusitis: experience of a single centreAndreas Sakkas, Thomas Lins, Majeed Rana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cellsDanielle Boller, Alexander Schramm, Kathrin T Doepfner, et al.
Cancer Letters|July 16, 2008
Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cellsJohannes H Schulte, Jutta Kirfel, Soyoung Lim, et al.
Pageof 23

Showing results (111-120 of 228) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compoundsKatleen De Preter, Sara De Brouwer, Tom Van Maerken, et al.
Frontiers in Genetics|June 17, 2022
Detection and Validation of Circular DNA Fragments Using Nanopore SequencingAlicia Isabell Tüns, Till Hartmann, Simon Magin, et al.
Cancer Immunology, Immunotherapy : CII|June 17, 2015
Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in miceAlexander Stermann, Nicole Huebener, Diana Seidel, et al.
Biomaterials|June 14, 2006
Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of miceMartin Rücker, Matthias W Laschke, Dominik Junker, et al.
DNA Repair|August 6, 2008
Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cellsJohannes H Schulte, Steffi Kuhfittig-Kulle, Ludger Klein-Hitpass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Translating expression profiling into a clinically feasible test to predict neuroblastoma outcomeAlexander Schramm, Jo Vandesompele, Johannes H Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Polo-like kinase 1 is a therapeutic target in high-risk neuroblastomaSandra Ackermann, Felix Goeser, Johannes H Schulte, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 6, 2025
Risk profile for recurrence after interdisciplinary treatment of odontogenic maxillary sinusitis: experience of a single centreAndreas Sakkas, Thomas Lins, Majeed Rana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cellsDanielle Boller, Alexander Schramm, Kathrin T Doepfner, et al.
Cancer Letters|July 16, 2008
Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cellsJohannes H Schulte, Jutta Kirfel, Soyoung Lim, et al.
Pageof 23